Newsletter | February 12, 2024

02.12.24 -- How Does The GAMP 5 Second Edition Update Look One Year Later?

SPONSOR

Successful Cell Bank Manufacturing

Getting it right the first time is important to you, and we can help you navigate the latest regulations. In this webinar, we will explore best practices for cell bank manufacturing and how to get the most out of your cell bank. Watch now!

FEATURED EDITORIAL

How Does The GAMP 5 Second Edition Update Look One Year Later?

Since ISPE published the GAMP 5 update last year, companies say the flexible approach to computerized system validation is helpful, but the new focus on critical thinking remains a challenge.

Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.

Bit.bio CEO, Dr. Mark Kotter doesn’t pull any punches when addressing the complexity involved in building out the marriage of computational and traditional science (and both computational and traditional scientists)

INDUSTRY INSIGHTS

An Introduction To Data Models And Modeling For Pharma 4.0

The foundation for standardizing data across a wide range of raw input data lies in the data model. Review six commonly asked questions people have when considering a data-modeling solution.

Viscosity-Reducing Excipients For Protein Formulation

We assess the viscosity-reducing capacities of excipients and excipient combinations. The findings demonstrate the impact of protein viscosity on injection force.

Resolving Common Single-Use Concerns

Demand for single-use production tools, components, and capabilities continues to grow as innovative cell therapies evolve. However, concerns and misconceptions abound regarding single-use solutions.

Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale

Explore data demonstrating the successful engineering of a single-use tangential flow filtration system designed to meet the specific requirements of ADC processes.

Introduction To mRNA Manufacturing

The COVID-19 virus has changed the course of scientific research around mRNA. Learn about mRNA manufacturing, the structure of a mRNA molecule, RNase-free considerations, and more.

Searching For A CDMO To Support Affordable Conjugate Vaccines

Learn how a CDMO that prioritizes custom, flexible partnership over a transactional relationship is crucial for long-term programs and for tailoring services to meet the needs of small-volume clients.

The Challenges Of Biopharmaceutical Quality

More than ever, the quality functions in biopharma manufacturing are under pressure due to regulatory and political scrutiny combined with a global market rife with complex quality standards.

Integration Of Quality Management And Manufacturing Automation Systems

Quality by design (QbD) is enormously valuable, but often underutilized, siloed, and not operationalized. Discover the benefits of enabling QbD with AI-driven quality operations and batch automation.

Partnering At Every Stage: Providing Capable Capacity For Manufacturing

Finding a CDMO partner with the requisite expertise, materials, external supply chain, and capacity is key to maximizing a therapy’s chances of commercial success.

Establishing Flexibility For Parenteral Cleanroom Manufacturing

Cleanroom systems are purposely designed to simplify implementation of the aseptic manufacturing space that the industry needs to meet future sterile injectable capacity demand.

Biopharma Drug Development Workflow And Techniques

Drug development is a long and complex process, and every step has specific goals. Explore the relevant objectives and techniques used in each stage of antibody drug development.

Single-Use Centrifuge: Green Features And Benefits

Explore the green features and process and operation footprint details of a single-use centrifuge being praised for generating less waste.

Advances In Protein A Chromatography

In this exploration of improvements in Protein A resins and process improvements in affinity chromatography, get the answers to several questions posed by industry experts.

Cleaning Proteins, RNA, And DNA From Lab Equipment

The best way to clean proteins, RNA, and DNA would be three separate methods. Explore the detailed steps and some of the helpful products.

SOLUTIONS

Streamlined Upstream Processing: Higher Yield, Lower Contamination Risk

Closing The Gap Between Theory And Therapy

Linking Antibody To Drug With Conjugation Technology For Better ADCs

Bionanoparticle Technology

Premier European Product Launch And Packaging Solution

Pros Of Working With A GMP-Based Plasmid Manufacturer

mRNA/LNP Development And Manufacturing Services

Conquer Complexities With Advanced Mass Spectrometry

Connect With Bioprocess Online: